Discontinued — last reported Q2 '23
STERIS Segment operating income — Revenue increased by 5.6% to $1.28B in Q2 2023 compared to the prior quarter. Year-over-year, this metric grew by 11.1%, from $1.16B to $1.28B. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market share or higher demand for the segment's products and services, whereas a decrease may signal market saturation or loss of competitive positioning.
This metric measures the total gross inflow of economic benefits generated by a specific business segment from its prima...
Comparable to segment-level net sales or revenue reported by peers in the medical device and healthcare services sectors.
ste_segment_segment_operating_income_revenues| Q2 '21 | Q3 '21 | Q4 '21 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | |
|---|---|---|---|---|---|---|---|
| Value | $968.42M | $1.20B | $1.21B | $1.16B | $1.20B | $1.22B | $1.28B |
| QoQ Change | — | +23.6% | +1.0% | -4.3% | +3.8% | +1.3% | +5.6% |
| YoY Change | — | — | — | +19.4% | +0.3% | +0.6% | +11.1% |